Amanda Freeman
Impact in
-
- Bone health and osteoporosis research
- Oncology top 10%
- Bone health and treatments
Papers in
-
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
-
- Pharmacogenetics and Drug Metabolism 2
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Sherry D. Holland (6 shared papers)Kenneth C. Lasseter (4 shared papers)Barry J. Gertz (4 shared papers)Masato Tomita (1 shared paper)Lawrence G. Raisz (1 shared paper)Scott G. Morham (1 shared paper)Yosuke Okada (1 shared paper)Joseph A. Lorenzo (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Clinical Therapeutics (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesJapanBelgium
In The Last Decade
Amanda Freeman
13 papers receiving 752 citations
Peers
Comparison fields: 5 of 91
- Orthopedics and Sports Medicine 139
- Oncology 271
- Pharmacology 173
- Pharmacology 72
- Infectious Diseases 95
Countries citing papers authored by Amanda Freeman
This map shows the geographic impact of Amanda Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Freeman more than expected).
Fields of papers citing papers by Amanda Freeman
This network shows the impact of papers produced by Amanda Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Freeman. The network helps show where Amanda Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 224 | |
| 2 | 2000 | 182 | |
| 3 | 2004 | 83 | |
| 4 | 1997 | 78 | |
| 5 | Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. | 1997 | 75 |
| 6 | 1999 | 40 | |
| 7 | 2012 | 29 | |
| 8 | 1999 | 26 | |
| 9 | 1994 | 26 | |
| 10 | Drug interactions between caspofungin and tacrolimus | 2001 | 19 |
| 11 | 1999 | 15 | |
| 12 | 2011 | 12 | |
| 13 | 1978 | 5 |
About Amanda Freeman
Amanda Freeman is a scholar working on Infectious Diseases, Pharmacology, Oncology, Physiology and Molecular Biology, having authored 13 papers that have together received 814 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Epilepsy research and treatment (2 papers), Antifungal resistance and susceptibility (2 papers), Inflammatory mediators and NSAID effects (2 papers), Bone health and treatments (2 papers), HIV/AIDS drug development and treatment (2 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (139 citations), Oncology (271 citations), Pharmacology (173 citations), Pharmacology (72 citations) and Infectious Diseases (95 citations). Amanda Freeman has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Sherry D. Holland, Kenneth C. Lasseter, Barry J. Gertz, Masato Tomita, Lawrence G. Raisz, Scott G. Morham, Yosuke Okada, Joseph A. Lorenzo, Carol C. Pilbeam and Arturo G. Porras. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Therapeutics, Clinical Pharmacology & Therapeutics and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.